London: A COVID-19 antiviral that can be taken at home was approved for use across the UK on Thursday.
With this, Britain has become the first country to give the go-ahead to Molnupiravir, jointly developed by Ridgeback Biotherapeutics and Merck, which is being considered a potential gamechanger in fighting the pandemic, especially in the case of the frailest and immunosuppressed, the BBC reported.
The UK’s Medicines and Healthcare products Regulatory Agency said the tablet has been authorised for use in people who have mild to moderate COVID and at least one risk factor for developing severe illness such as obesity, old age, diabetes or heart disease.
The pill works by interfering with the virus’ replication. This prevents it from multiplying, keeping virus levels low in the body, and thus, reduce the severity of the disease, it said.
The drug needs to be given within five days of symptoms developing to be most effective.
Britain has agreed to purchase 480,000 courses with the first deliveries expected by mid-November.
Molnupiravir will soon be offered to patients, both vaccinated and unvaccinated, in a national study to help protect those most at risk from the virus over the winter, it added.
Mumbai: The first day of the IPL mega player auction at Jeddah threw up several…
Bhubaneswar: The Odisha government has handed over the investigation into the attack on Dhramasala MLA…
Bhubaneswar: The Commissionerate of Police on Sunday issued an advisory for movement of vehicular traffic…
New York: Now that President-elect Donald Trump has tasked Elon Musk with the responsibility of co-heading…
Bhubaneswar: The Odisha government has warned its employees of stern action for sub-letting their allotted…
Mumbai: There has been a lot of talk over AR Rahman and his wife Saira…
Sundargarh: The North Odisha Development Council (NODC) would be formed in 2-3 months, said Chief…
Puri: Director General of Police (DGP) YB Khurania on Sunday reviewed the security arrangements for…